Capcom’s Resident Evil Requiem Wins Most Honors with Four Awards at the Gamescom Awards 2025!
Capcom Co., Ltd. (TOKYO:9697) today announced that Resident Evil Requiem won the most honors at the Gamescom Awards 2025 with a total of four awards, which were announced at Gamescom, a game show held from August 20-24, 2025, in Germany. Further, Capcom was also awarded Best Lineup at the show.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250825276939/en/
Resident Evil Requiem Logo
The Gamescom Awards are one of the largest European game awards, where winners are chosen from the titles shown at the game show by a jury comprised of game industry professionals and the associated community, along with voting from game players. Winner of four awards, Resident Evil Requiem is the latest title in the Resident Evil series and is scheduled for release on February 27, 2026. Many showgoers were able to try the game at this year’s Gamescom, where the world’s first playable demo of the title was exhibited. The title garnered high praise for its unprecedented sense of immersion, as well as its innovative gameplay, all made possible by RE ENGINE, Capcom’s proprietary game development engine. This led the title to win the award for Most Epic, which recognizes games that captivate players with breath-taking, awe-inspiring experiences.
Moreover, Resident Evil Requiem was also awarded Best Sony PlayStation Game, which is given to the most outstanding game for PlayStation at Gamescom, Best Visuals, which honors titles that have the most impressive graphics, as well as Best Audio, which is awarded to games with excellent immersive audio experiences. Additionally, Capcom was awarded Best Lineup at Gamescom 2025, an honor that goes to the exhibitor with the most compelling overall lineup of games as decided by a jury. Altogether, Capcom garnered significant attention from the numerous awards it won at Gamescom, highlighting the acclaim the company’s titles have received from fans around the world.
Capcom remains firmly committed to satisfying the expectations of all users by leveraging its industry leading game development capabilities in order to create highly entertaining gameplay experiences.
ABOUT CAPCOM
Capcom is a leading worldwide developer, publisher and distributor of interactive entertainment for game consoles, PCs, handheld and wireless devices. Founded in 1983, the company has created hundreds of games, including groundbreaking franchises Resident Evil™, Monster Hunter™, Street Fighter™, Mega Man™, Devil May Cry™ and Ace Attorney™. Capcom maintains operations in the U.S., U.K., Germany, France, Hong Kong, Taiwan, Singapore and Tokyo, with corporate headquarters located in Osaka, Japan. More information about Capcom can be found at https://www.capcom.co.jp/ir/english/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250825276939/en/
Contacts
Capcom Public Relations & Investor Relations Section
+81-6-6920-3623
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MultiBank Group Completed First $MBG Buyback & Burn, Removing 4.86M Tokens After Record H1 2025 Financial Results.27.8.2025 13:40:00 EEST | Press release
MultiBank Group, the world’s largest financial derivatives institution, has announced the successful execution of its buyback and burn program, permanently removing 4,860,000 $MBG tokens from circulation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250827632341/en/ MultiBank Group Completed First $MBG Buyback & Burn, Removing 4.86M Tokens After Record H1 2025 Financial Results. The milestone follows the Group’s record-breaking financial results, with H1 2025 revenue reaching $209 million and an average daily trading turnover of $36 billion since the Token Generation Event on July 22. The $MBGBuyback and Burn program underscores MultiBank Group’s commitment to rewarding its community while strengthening the long-term fundamentals of the $MBG Utility Token. By reducing supply, the Group is actively driving scarcity and reinforcing token value. The initiative is structured to scale significantly, with up to $58.2 million wor
Ant International, Standard Chartered and Swift Collaborate to Pioneer Bank-to-Wallet Payment Solution Backed by ISO 2002227.8.2025 13:35:00 EEST | Press release
Supported by Swift’s trusted infrastructure, Ant International, a leading global digital payment, digitisation and financial technology provider, and Standard Chartered Bank have launched live production trials for a bank-to-wallet payment solution using the ISO 20022 financial messaging standards. Through Alipay+, the global wallet gateway service under Ant International, the first transactions were completed successfully between a Standard Chartered Bank customer account and a partner e-wallet. Through simplifying global money transfers, the innovative solution leverages the Swift network of over 11,500 financial institutions in more than 200 countries and territories to connect to 1.7 billion user accounts on the 36 global digital wallets in the Alipay+ ecosystem, especially across fast-growing Asian markets. Michael Spiegel, Global Head of Transaction Banking, Standard Chartered said: “We are pleased to be the bank of choice to conceptualise, test and deliver this innovation. It is
Compass Pathways to Participate in Four Investor Conferences in September27.8.2025 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following September investor conferences: Cantor Global Healthcare Conference – New York, NY: Fireside chat at 1:35 PM EST on September 3, 2025 Morgan Stanley 23rd Annual Global Healthcare Conference – New York, NY: Fireside chat at 10:45 AM EST on September 9, 2025 H.C. Wainwright 27th Annual Global Investment Conference – New York, NY: Fireside chat at 9:00 AM EST on September 9, 2025 TD Cowen’s 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit: Virtual fireside chat at 10:40 AM EST on September 17, 2025 A live audio webcast of these events will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a
From Paris with Love : KARL LAGERFELD’s Fall/Winter 2025 Campaign27.8.2025 13:02:00 EEST | Press release
Paris...meet Paris. KARL LAGERFELD is proud to unveil its Fall/Winter 2025 campaign, From Paris with Love, starring global icon Paris Hilton. Blending her one-of-a-kind charisma with the brand’s unmistakable aesthetic, the campaign playfully unites two cultural forces who have shaped pop culture on their own terms. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250826688190/en/ KARL LAGERFELD Fall Winter 25 Campaign - Paris Hilton - ©Chris Colls Embracing both an elegant and witty visual dialogue between Paris Hilton and the Maison’s Parisian roots, the campaign explores themes of glamour, individuality, and attitude—channeling the irreverent spirit and sharp sophistication that defined Karl Lagerfeld himself. The result is a celebration of authenticity and self-expression, presenting Paris in a fresh, unexpected light and reframing her renowned image through the lens of the brand’s distinctive point of view. The FW25 360 ca
European Commission Approves TEVIMBRA ® as Neoadjuvant/Adjuvant NSCLC Treatment Ahead of Late-Breaking Data Presentation at WCLC 202527.8.2025 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Commission (EC) has approved TEVIMBRA (tislelizumab), in combination with platinum-containing chemotherapy as neoadjuvant treatment followed by TEVIMBRA monotherapy as adjuvant treatment, for adult patients with resectable non-small cell lung cancer (NSCLC) at high risk of recurrence. The EC approval is based on results from the Phase 3 RATIONALE-315 trial. The preplanned final analysis of RATIONALE-315 demonstrates that TEVIMBRA, combined with platinum-based chemotherapy before surgery and continued as monotherapy afterward, showed statistically significant and clinically meaningful benefit in overall survival (OS) compared with chemotherapy combined with placebo. Data from this trial will be presented as a Late-Breaking Abstract (#MA04.08)1 at the IASLC 2025 World Conference on Lung Cancer (WCLC) hosted by the International Association for the Study of Lung Cance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom